Page last updated: 2024-10-18

glycine and Pantothenate Kinase-Associated Neurodegeneration

glycine has been researched along with Pantothenate Kinase-Associated Neurodegeneration in 2 studies

Pantothenate Kinase-Associated Neurodegeneration: A rare autosomal recessive degenerative disorder which usually presents in late childhood or adolescence. Clinical manifestations include progressive MUSCLE SPASTICITY; hyperreflexia; MUSCLE RIGIDITY; DYSTONIA; DYSARTHRIA; and intellectual deterioration which progresses to severe dementia over several years. (From Adams et al., Principles of Neurology, 6th ed, p972; Davis & Robertson, Textbook of Neuropathology, 2nd ed, pp972-929)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, YH1
Tang, BS1
Zhao, AL1
Xia, K1
Long, ZG1
Guo, JF1
Westaway, SK1
Hayflick, SJ1
Kazek, B1
Jamroz, E1
Gencik, M1
Jezela Stanek, A1
Marszal, E1
Wojaczynska-Stanek, K1

Other Studies

2 other studies available for glycine and Pantothenate Kinase-Associated Neurodegeneration

ArticleYear
Novel compound heterozygous mutations in the PANK2 gene in a Chinese patient with atypical pantothenate kinase-associated neurodegeneration.
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:7

    Topics: Adult; Asian People; Asparagine; Aspartic Acid; DNA Mutational Analysis; Exons; Glycine; Heterozygot

2005
A novel PANK2 gene mutation: clinical and molecular characteristics of patients short communication.
    Journal of child neurology, 2007, Volume: 22, Issue:11

    Topics: Adolescent; Arginine; Child; Glycine; Humans; Male; Mutation; Pantothenate Kinase-Associated Neurode

2007